Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stem Cell Research

Free Subscription Articles published in Leuk Res Retrieve available abstracts of 22 articles: HTML format

Single Articles

July 2022
1. VIRK H, Rathore S, Anshu A, Jamwal M, et al
   Imatinib responsive erythrocytosis in a patient with FIP1L1::PDGFRA rearranged myeloid neoplasm with hypereosinophilia - Another manifestation of a stem cell neoplasm.
   Leuk Res. 2022;121:106922.
   PubMed    
   
   
   
2. BARKHORDAR M, Kasaeian A, Janbabai G, Mousavi SA, et al
   Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-yea
   Leuk Res. 2022;120:106918.
   PubMed     Abstract available
   
   
   
3. BOSTANKOLU DEGIRMENCI B, Yegin ZA, Dikyar A, Aydin Kaynar L, et al
   Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia.
   Leuk Res. 2022;118:106870.
   PubMed     Abstract available
   
   
   February 2022
4. KUSNE Y, Xie Z, Patnaik MM
   Clonal hematopoiesis: Molecular and clinical implications.
   Leuk Res. 2022;113:106787.
   PubMed     Abstract available
   
   
   November 2021
5. MINAKATA D, Fujiwara SI, Murahashi R, Nakashima H, et al
   Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysis.
   Leuk Res. 2021;112:106750.
   PubMed     Abstract available
   
   
   September 2021
6. TANG S, Lu Y, Zhang P, Chen D, et al
   Lenalidomide, bortezomib and dexamethasone followed by tandem- autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma.
   Leuk Res. 2021;110:106710.
   PubMed     Abstract available
   
   
   
7. SAPELLI J, Filho JS, Matias Vieira GM, Moura FL, et al
   BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas.
   Leuk Res. 2021;110:106689.
   PubMed     Abstract available
   
   
   
8. ESFANDBOD M, Enshaei M, Monzavi SM, Kabootari M, et al
   Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement.
   Leuk Res. 2021;111:106703.
   PubMed     Abstract available
   
   
   July 2021
9. PLESA A, Roumier C, Gutrin J, Larcher MV, et al
   Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
   Leuk Res. 2021;111:106673.
   PubMed    
   
   
   June 2021
10. MOHAN M, Hari P, Szabo A, Dhakal B, et al
    Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation.
    Leuk Res. 2021;109:106648.
    PubMed    
    
    
    
11. ZHANG Y, Feng S
    The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leuk Res. 2021;109:106647.
    PubMed     Abstract available
    
    
    
12. XUE E, Lorentino F, Pavesi F, Assanelli A, et al
    Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience.
    Leuk Res. 2021;109:106642.
    PubMed     Abstract available
    
    
    
13. MIYAUCHI J, Kawaguchi H
    The in vitro effects of hepatoblastoma cells on the growth and differentiation of blasts in transient abnormal myelopoiesis associated with Down syndrome.
    Leuk Res. 2021;105:106570.
    PubMed     Abstract available
    
    
    May 2021
14. YASUDA S, Najima Y, Konishi T, Yamada Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Leuk Res. 2021;108:106627.
    PubMed     Abstract available
    
    
    
15. FIEGLE E, Crysandt M, Bouillon AS, Silling G, et al
    Successful allogeneic stem cell transplantation of a patient with Werner syndrome and acute myeloid leukemia.
    Leuk Res. 2021 May 5:106609. doi: 10.1016/j.leukres.2021.106609.
    PubMed    
    
    
    April 2021
16. SPEROTTO A, Gottardi M, Candoni A, Toffoletti E, et al
    WT1 - Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant.
    Leuk Res. 2021;108:106587.
    PubMed    
    
    
    
17. KATO H, Taji H, Kodaira T, Kinoshita T, et al
    Long-term engraftment stability of umbilical cord blood cells preserved in -135 degrees C mechanical freezers.
    Leuk Res. 2021;107:106590.
    PubMed    
    
    
    
18. MARTINEZ-ROCA A, Rodriguez-Lobato LG, Ballestar N, Gallego C, et al
    Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak.
    Leuk Res. 2021;106:106589.
    PubMed    
    
    
    
19. LI S, Gu J, Nan W, Zhang N, et al
    Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients.
    Leuk Res. 2021;105:106574.
    PubMed     Abstract available
    
    
    November 2020
20. YANAGISAWA B, Perkins B, Karantanos T, Levis M, et al
    Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
    Leuk Res. 2020;99:106477.
    PubMed     Abstract available
    
    
    
21. KUNIMOTO H, Nakajima H
    Clonal hematopoiesis: Molecular basis and clinical relevance.
    Leuk Res. 2020;98:106457.
    PubMed     Abstract available
    
    
    September 2020
22. LIU T, Ahmed T, Krysiak K, Shirai CL, et al
    Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice.
    Leuk Res. 2020;96:106428.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: